Ro Secures $500M Funding to Revolutionize Direct-to-Patient Healthcare

Ro, the groundbreaking direct-to-patient healthcare company, has announced a significant funding milestone, successfully raising an impressive $500 million to further its mission of providing high-quality, affordable healthcare without the complexities of insurance. Established in 2017, Ro has transformed how patients access medical care by uniquely integrating telehealth services, in-home care, diagnostics, labs, and pharmacy solutions into a seamless, vertically integrated platform. This innovative approach not only enhances the patient experience but also ensures that healthcare is both accessible and personalized. With over eight million digital healthcare visits facilitated across nearly every county in the United States—impacting an astounding 98% of primary care deserts—Ro has proven its commitment to filling critical gaps in healthcare access. The newly acquired funds will be instrumental in expanding Ro's offerings, including its pioneering Workpath in-home care API and Kit at-home diagnostic testing service, both of which are already empowering other healthcare companies to deliver patient-centric solutions. This infusion of capital underscores the growing demand for accessible healthcare solutions and positions Ro to enhance its infrastructure, scale operations, and innovate further in the healthcare space. With this strategic investment, Ro is poised to continue its impactful journey of making healthcare not just a right, but a reality for all patients, regardless of their geographical location or insurance status.